We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Wegovy improved functional class vs. placebo at 1 year ...
BURLINGTON, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to ...
An increasing proportion of patients with heart failure receive a combination of four medications shown to improve prognosis ...
The SGLT2 inhibitor medicines have changed how heart failure is managed. Originally sodium-glucose cotransporter 2 (SGLT2) inhibitors were used to lower blood sugar levels in people who have type 2 ...
Please provide your email address to receive an email when new articles are posted on . People who used e-cigarettes had a 19% elevated risk for heart failure compared with never users, according to a ...
AB-1002 is an investigational one-time gene therapy administered directly to the heart to promote production of a modified ...
Panelists discuss how SGLT2 inhibitors evolved from diabetes medications to become foundational heart failure therapy with class I recommendations across the ejection fraction spectrum, providing ...
SALT LAKE CITY & SAN FRANCISCO--(BUSINESS WIRE)--TikkunLev Therapeutics, a biotechnology company developing precision therapies targeting the causal disease biology of failing heart muscle, today ...
Some people with heart failure need to take multiple medicines each day in order to keep their symptoms under control. Heart failure not only leads to issues in the heart but other organs in the body ...
Heart failure (HF) imposes a large and growing burden on the population, with a prevalence that is projected to increase to more than 8 million adults by 2030. The high risk of morbidity and mortality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results